share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Director Hockfield Susan

Pfizer | 4: Statement of changes in beneficial ownership of securities-Director Hockfield Susan

輝瑞 | 4:持股變動聲明-董事 Hockfield Susan
美股sec公告 ·  04/27 01:28
牛牛AI助理已提取核心訊息
Susan Hockfield, a reporting person for Pfizer Inc [PFE], has engaged in a transaction involving the company's stock. The action took place on April 25, 2024. However, the details regarding the nature of the transaction, such as the number of shares traded, the transaction price, and the resulting ownership stake, have not been disclosed. Investors are advised to monitor Pfizer's filings for further details on transactions by insiders.
Susan Hockfield, a reporting person for Pfizer Inc [PFE], has engaged in a transaction involving the company's stock. The action took place on April 25, 2024. However, the details regarding the nature of the transaction, such as the number of shares traded, the transaction price, and the resulting ownership stake, have not been disclosed. Investors are advised to monitor Pfizer's filings for further details on transactions by insiders.
輝瑞公司 [PFE] 的舉報人蘇珊·霍克菲爾德參與了一項涉及該公司股票的交易。該行動於2024年4月25日舉行。但是,有關交易性質的細節,例如交易的股票數量、交易價格以及由此產生的所有權,尚未披露。建議投資者監督輝瑞的申報,以了解有關內部人士交易的更多細節。
輝瑞公司 [PFE] 的舉報人蘇珊·霍克菲爾德參與了一項涉及該公司股票的交易。該行動於2024年4月25日舉行。但是,有關交易性質的細節,例如交易的股票數量、交易價格以及由此產生的所有權,尚未披露。建議投資者監督輝瑞的申報,以了解有關內部人士交易的更多細節。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。